SAN FRANCISCO and SUZHOU, China, Nov. 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a wo ...

Investor call to review preliminary data from the PIKture-01 trial is now planned for Tuesday, December 10th, at 7 a.m. CT ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

In early 20th-century Cleveland, smokestacks from steel mills cast long shadows across the city, draping it in a gray haze.

The tour was hosted by Madame Architect, a media platform dedicated to advancing the work of women in the design industry.

On September 12 th, Bright Minds Biosciences announced the initiation of the BREAKTHROUGH Study, an open-label Phase 2 clinical trial evaluating the safety, tolerability, and efficacy of BMB-101 in ...

A number of exhibitors at the recent EuroTier Show in Germany say they are concerned about ‘Chinese corporate spying’ at the ...

Workshop, poster and oral presentation of data given ... tests and other markers of inflammation and injury in patients. The Company is currently advancing the development of GRI-0621 in a Phase 2a, ...

Prof. Robert Sutton to deliver plenary presentation on Phase 2b CARPO trial of AuxoraTM in Acute Pancreatitis (AP) at ...

The state of the Airbnb home in the viral clip sparked debate, with one saying, "I used to do this, don't bother now." ...

The three-day Carbon Fiber Conference, held in Charleston, S.C., addressed a variety of carbon fiber/composites related ...